Crinecerfont Dosage
Medically reviewed by Drugs.com. Last updated on Feb 11, 2025.
Applies to the following strengths: 25 mg; 50 mg; 100 mg; 50 mg/mL
Usual Adult Dose for:
Usual Pediatric Dose for:
Additional dosage information:
Usual Adult Dose for Congenital Adrenal Hyperplasia
Initial dose: 100 mg orally twice a day, with the morning and evening meals
Use: Adjunctive treatment to glucocorticoid replacement to control androgens in patients with congenital adrenal hyperplasia (CAH)
Usual Pediatric Dose for Congenital Adrenal Hyperplasia
4 years and older:
- Weight 10 kg to less than 20 kg: 25 mg orally twice daily
- Weight 20 kg to less than 55 kg: 50 mg orally twice daily
- Weight at least 55 kg: 100 mg orally twice daily
Comment:
- Take with the morning and evening meals.
Use: Adjunctive treatment to glucocorticoid replacement for the control of androgens in patients with congenital adrenal hyperplasia (CAH)
Renal Dose Adjustments
Not recommended in severe renal impairment or end-stage renal disease.
Liver Dose Adjustments
Data not available
Dose Adjustments
Dosage Modifications for Concomitant Use with Strong CYP450 3A4 Inducers:
- Adult: Increase to 200 mg orally twice daily, with the morning and evening meals
- Pediatric:
- Weight 10 kg to less than 20 kg: 50 mg orally twice daily, with the morning and evening meals
- Weight 20 kg to less than 55 kg: 100 mg orally twice daily, with the morning and evening meals
- Weight at least 55 kg: 200 mg orally twice daily, with the morning and evening meals
Dosage Modifications for Concomitant Use with Moderate CYP450 3A4 Inducers:
- Adult: Increase to 100 mg orally with the morning meal and 200 mg with the evening meal
- Pediatric:
- Weight 10 kg to less than 20 kg: 25 mg orally with the morning meal and 50 mg orally with the evening meal
- Weight 20 kg to less than 55 kg: 50 mg orally with the morning meal and 100 mg orally with the evening meal
- Weight at least 55 kg: 100 mg orally with the morning meal and 200 mg orally with the evening meal
Precautions
CONTRAINDICATIONS:
- Hypersensitivity to the active component or any of the ingredients
Safety and efficacy have not been established in patients younger than 4 years.
Consult WARNINGS section for additional precautions.
Dialysis
Data not available
Other Comments
Administration advice:
- Take with a meal.
Storage requirements:
- Capsules:
- Store at 15C to 25C (59F to 77F).
- Do not freeze.
- Solution:
- Dispense and store in original container in an upright position.
- Keep unopened bottles refrigerated at 2C to 8C (36F to 46F).
- Once opened, keep bottles refrigerated at 2C to 8C (36F to 46F) or at room temperature (15C to 25C [59F to 77F]). Discard unused portion 30 days after opening.
- Do not freeze.
Patient advise:
- Read the US FDA-approved patient labeling (Patient Information and Instructions for Use).
More about crinecerfont
- Check interactions
- Compare alternatives
- Side effects
- During pregnancy
- Drug class: adrenal corticosteroid inhibitors
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.